Acute Intermittent Porphyria as a Rare Challenging Neuro-Metabolic Disease; a Case Report
学术急诊医学档案,
卷 10 编号 1 (2022),
1 一月 2022
,
第 e74 页
https://doi.org/10.22037/aaem.v10i1.1780
摘要
Porphyria is a challenging metabolic disease due to its heterogeneous presentation symptoms and its difficult diagnosis. Many affected individuals can complain of recurrent neuro-visceral attacks per year, some of which may be persistent and life-threatening, which is confusing if there is no established diagnosis. Although the motor manifestations, autonomic changes and seizure are highly suggestive, the diagnosis is often overlooked and needs confirmatory genetic testing. To the best of our knowledge, the acute intermittent porphyria (AIP) reported in this case, involving severe electrolyte disturbances and rapid severe weakness is a challenging neuro-metabolic case and is extremely rare worldwide. Here, we reported a case of AIP in a young girl who presented to the emergency department of Al-Araby international Hospital, Monufia, Egypt with severe abdominal pain, constipation, and headache which had started 10 days ago. It seems that the diagnosis of porphyria should be considered particularly in those patients with abdominal complaints associated with electrolyte disturbances, seizures, and severe progressive neuropathy.
- Electrolyte Imbalance
- Porphyria
- Acute Intermittent
- Polyneuropathies
##submission.howToCite##
参考
Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute intermittent porphyria: current perspectives and case presentation. Ther Clin Risk Manag. 2019;15:1443-51.
Ma Y, Teng Q, Zhang Y, Zhang S. Acute intermittent porphyria: focus on possible mechanisms of acute and chronic manifestations. Intractable Rare Dis Res. 2020;9(4):187-95.
Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164-77.
Cardenas JL, Guerrero C. Acute intermittent porphyria: general aspects with focus on pain. Curr Med Res Opin. 2018;34(7):1309-15.
Bustad HJ, Kallio JP, Vorland M, Fiorentino V, Sandberg S, Schmitt C, et al. Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. Int J Mol Sci. 2021;22(2):675.
Alqwaifly M, Bril V, Dodig D. Acute intermittent porphyria: a report of 3 cases with neuropathy. Case Rep Neurol. 2019;11(1):32-6.
Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine. 2005;84(1):48-60.
Schutte C-M, Van der Meyden CH, Van Niekerk L, Kakaza M, Van Coller R, Ueckermann V, et al. Severe porphyric neuropathy-importance of screening for porphyria in Guillain-Barre syndrome: clinical alert. S Afr Med J. 2016;106(1):44-7.
- 摘要 ##plugins.themes.ojsPlusA.frontend.article.viewed##: 970 ##plugins.themes.ojsPlusA.frontend.article.times##
- pdf (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 418 ##plugins.themes.ojsPlusA.frontend.article.times##
##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##
##plugins.block.makeSubmission.linkLabel##
SJR
COPE
